353 related articles for article (PubMed ID: 34667303)
1. Prostate zones and cancer: lost in transition?
Ali A; Du Feu A; Oliveira P; Choudhury A; Bristow RG; Baena E
Nat Rev Urol; 2022 Feb; 19(2):101-115. PubMed ID: 34667303
[TBL] [Abstract][Full Text] [Related]
2. Analysis of differences in clinicopathological features between prostate cancers located in the transition and peripheral zones.
Sakai I; Harada K; Kurahashi T; Yamanaka K; Hara I; Miyake H
Int J Urol; 2006 Apr; 13(4):368-72. PubMed ID: 16734852
[TBL] [Abstract][Full Text] [Related]
3. Single-cell RNA sequencing of human prostate basal epithelial cells reveals zone-specific cellular populations and gene expression signatures.
Vellky JE; Wu Y; Moline D; Drnevich J; Maienschein-Cline M; Valyi-Nagy K; Kajdacsy-Balla A; Vander Griend DJ
J Pathol; 2024 Feb; 262(2):212-225. PubMed ID: 37984408
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of prostate cancer originating from the transition zone.
King CR; Ferrari M; Brooks JD
Urol Oncol; 2009; 27(6):592-7. PubMed ID: 18799332
[TBL] [Abstract][Full Text] [Related]
5. Prostate carcinoma with positive margins at radical prostatectomy: role of tumour zonal origin in biochemical recurrence.
O'Neil LM; Walsh S; Cohen RJ; Lee S
BJU Int; 2015 Oct; 116 Suppl 3():42-8. PubMed ID: 26218868
[TBL] [Abstract][Full Text] [Related]
6. Is transition zone biopsy valuable in benign prostatic hyperplasia patients with serum prostate-specific antigen >10 ng/ml and prior negative peripheral zone biopsy?
Abdel-Khalek M; Sheir KZ; El-Baz M; Ibrahiem el-H
Scand J Urol Nephrol; 2005; 39(1):49-55. PubMed ID: 15764271
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the biological features between prostate cancers arising in the transition and peripheral zones.
Sakai I; Harada K; Hara I; Eto H; Miyake H
BJU Int; 2005 Sep; 96(4):528-32. PubMed ID: 16104904
[TBL] [Abstract][Full Text] [Related]
8. Differences in biopsy features between prostate cancers located in the transition and peripheral zone.
Augustin H; Erbersdobler A; Graefen M; Jaekel T; Haese A; Huland H; Hammerer PG
BJU Int; 2003 Apr; 91(6):477-81. PubMed ID: 12656897
[TBL] [Abstract][Full Text] [Related]
9. Tumour grade, proliferation, apoptosis, microvessel density, p53, and bcl-2 in prostate cancers: differences between tumours located in the transition zone and in the peripheral zone.
Erbersdobler A; Fritz H; Schnöger S; Graefen M; Hammerer P; Huland H; Henke RP
Eur Urol; 2002 Jan; 41(1):40-6. PubMed ID: 11999464
[TBL] [Abstract][Full Text] [Related]
10. Should transition zone biopsies be added to 12-core systematic biopsies of the prostate?
Hwang SI; Lee HJ; Cho JY; Kim SH; Lee SE; Byun SS; Hong SK; Choe GY
J Clin Ultrasound; 2009 Jun; 37(5):281-4. PubMed ID: 19309725
[TBL] [Abstract][Full Text] [Related]
11. Morphometric analysis of prostate zonal anatomy using magnetic resonance imaging: impact on age-related changes in patients in Japan and the USA.
Matsugasumi T; Fujihara A; Ushijima S; Kanazawa M; Yamada Y; Shiraishi T; Hongo F; Kamoi K; Okihara K; de Castro Abreu AL; Oishi M; Shin T; Palmer S; Gill IS; Ukimura O
BJU Int; 2017 Oct; 120(4):497-504. PubMed ID: 28220583
[TBL] [Abstract][Full Text] [Related]
12. Zonal origin of localized prostate cancer does not affect the rate of biochemical recurrence after radical prostatectomy.
Chun FK; Briganti A; Jeldres C; Erbersdobler A; Schlomm T; Steuber T; Gallina A; Walz J; Perrotte P; Huland H; Graefen M; Karakiewicz PI
Eur Urol; 2007 Apr; 51(4):949-55; discussion 955. PubMed ID: 16904818
[TBL] [Abstract][Full Text] [Related]
13. Relationship between prostatic epithelial volume and serum prostate-specific antigen levels.
Lepor H; Wang B; Shapiro E
Urology; 1994 Aug; 44(2):199-205. PubMed ID: 7519380
[TBL] [Abstract][Full Text] [Related]
14. Transition zone biopsy and prediction of extraprostatic extension at radical prostatectomy.
Onder AU; Yaycioglu O; Ataus S; Gul U; Demirkesen O; Yalcin V; Solok V
Int J Urol; 2003 Jun; 10(6):302-6; discussion 307-8. PubMed ID: 12757598
[TBL] [Abstract][Full Text] [Related]
15. Are transition zone biopsies still necessary to improve prostate cancer detection? Results from the tyrol screening project.
Pelzer AE; Bektic J; Berger AP; Halpern EJ; Koppelstätter F; Klauser A; Rehder P; Horninger W; Bartsch G; Frauscher F
Eur Urol; 2005 Dec; 48(6):916-21; discussion 921. PubMed ID: 16126324
[TBL] [Abstract][Full Text] [Related]
16. Relationship between T2 relaxation and apparent diffusion coefficient in malignant and non-malignant prostate regions and the effect of peripheral zone fractional volume.
Simpkin CJ; Morgan VA; Giles SL; Riches SF; Parker C; deSouza NM
Br J Radiol; 2013 Apr; 86(1024):20120469. PubMed ID: 23426849
[TBL] [Abstract][Full Text] [Related]
17. Volume-specific cutoffs are necessary for reproducible application of prostate-specific antigen density of the transition zone in prostate cancer detection.
Taneja SS; Tran K; Lepor H
Urology; 2001 Aug; 58(2):222-7. PubMed ID: 11489705
[TBL] [Abstract][Full Text] [Related]
18. Correlation between serum prostate specific antigen levels and the volume of the individual glandular zones of the human prostate.
Hammerer PG; McNeal JE; Stamey TA
J Urol; 1995 Jan; 153(1):111-4. PubMed ID: 7526003
[TBL] [Abstract][Full Text] [Related]
19. [Clinicopathological study of prostate cancer patients who had a serum PSA level of more than 20 ng/ml and were treated by a radical prostatectomy].
Udo K; Otsubo S; Sakamoto N; Iguchi A
Nihon Hinyokika Gakkai Zasshi; 2007 Jul; 98(5):685-90. PubMed ID: 17682447
[TBL] [Abstract][Full Text] [Related]
20. Improving prostate cancer detection with an extended-core transrectal ultrasonography-guided prostate biopsy protocol.
Durkan GC; Sheikh N; Johnson P; Hildreth AJ; Greene DR
BJU Int; 2002 Jan; 89(1):33-9. PubMed ID: 11849157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]